NovaBone has received the Brazilian ANVISA Good Manufacturing Practices (GMP) medical device certificate.
ANVISA is Brazil’s equivalent to the US Food and Drug Administration (FDA), and is responsible for the oversight of all medical device and pharmaceuticals in the Brazilian market. The entire portfolio of NovaBone dental and orthopaedic products is now available for Brazilian distribution.
“This important certificate extends our distribution to the largest market in South America,” says Art Wotiz, president of NovaBone.
